For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a genuine breakthrough . These groundbreaking therapies stabilize the transthyretin protein, slowing its destructive build-up and lessening th